Drug intelligence / Profile preview

Epinephrine Cyclops®

Development stage
Unknown
Lead developer
PureIMS
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Inhalation
01

Overview

Epinephrine Cyclops® is a pre-loaded, disposable, breath-powered dry powder inhaler (DPI) developed by PureIMS for the fast and reliable treatment of allergies and impending anaphylaxis. It utilizes the proprietary Cyclops® technology to deliver epinephrine (adrenaline), a small molecule catecholamine agonist that acts on adrenergic receptors. The device is designed to be credit card-sized and user-friendly, providing a non-invasive alternative to traditional intramuscular epinephrine auto-injectors. Clinical data indicates that inhalation via the Cyclops® platform achieves therapeutic plasma concentrations within five minutes, offering a faster and less variable time to peak concentration compared to intramuscular administration. The drug is currently in clinical development, with Phase 1 trials completed and Phase 2 trials in preparation.

Brand names
Epinephrine Cyclops®
Other names
epinephrineadrenaline
02

Targets

ADRA1A (α1A)ADRA2A (α2A)ADRB1 (β1)ADRB2 (β2)

Beyond the preview

Go deeper on Epinephrine Cyclops®.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epinephrine Cyclops®.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call